Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / Training / Seminars and Symposia / Drug Development in AML: Optimizing Treatment with Timed Sequential Therapy in Newly Diagnosed AML Patients

Drug Development in AML: Optimizing Treatment with Timed Sequential Therapy in Newly Diagnosed AML Patients

Joshua Zeidner, MD, Sidney Kimmel Cancer Center, Johns Hopkins Hospital
When Nov 07, 2013
from 08:00 AM to 09:00 AM
Where 3101 Physicians Office Building
Add event to calendar iCal

Sponsored by UNC School of Medicine Hematology/Oncology